DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers - Wikidata - wikimedia - TriplyDB

DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers

DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers

http://www.wikidata.org/entity/Q36352752

about

Structure of the thermally stable Zika virus Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus Dissecting Virus Infectious Cycles by Cryo-Electron Microscopy Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures Dengue Fever: Causes, Complications, and Vaccine Strategies Recent advances in understanding dengue Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Dengue: an update on treatment options Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody Dengue: knowledge gaps, unmet needs, and research priorities AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis A human antibody against Zika virus crosslinks the E protein to prevent infection Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers.Immune correlates for dengue vaccine development A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.Evolutionarily Successful Asian 1 Dengue Virus 2 Lineages Contain One Substitution in Envelope That Increases Sensitivity to Polyclonal Antibody Neutralization.Conformational changes in intact dengue virus reveal serotype-specific expansion.Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.Immune correlates of protection for dengue: State of the art and research agenda.New developments in flavivirus drug discovery.The Role of the Membrane in the Structure and Biophysical Robustness of the Dengue Virion Envelope.Molecular basis of antibody-mediated neutralization and protection against flavivirus.The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.AChiralPentagonalPolyhedralFramework forCharacterizingVirusCapsidStructures.Vaccines licensed and in clinical trials for the prevention of dengue.Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development.Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials.Dengue virus: Bumps in the road to therapeutic antibodies.Antimicrobials: Novel antibodies defeat dengue virus.

P2860

Q24082710-72B4A825-B82B-4F56-AA3C-444F58549902 Q26247258-2E06EC83-78BB-4921-97B4-0AC0E1BE4325 Q26700032-B7FF82B9-1520-4EA6-AD0E-C45C8AA74CC2 Q26700070-28BEBDD4-CB00-4B5C-A4D3-A86BED95D7DE Q26700082-42AC677C-E476-4CB0-A2A7-D210DC7567FE Q26766156-71F3B17C-C4E1-41C2-8F9E-A6CBBA7FAC06 Q27493140-F446D9E0-7B30-4DBD-9514-F1B45055B7A0 Q27654848-95F7478B-01B7-4FAF-A656-AD2BE8BE39A7 Q28085044-98E6CDEA-1B5F-4141-B13F-90F1FB2665D9 Q28114614-8FB84C38-2FCD-4807-A494-4E2FC6868603 Q28119651-1CDF7250-5C57-4633-9F34-0E95C1CE6316 Q28550496-8EEE7D6D-0601-4DDA-99CB-37477EB0D420 Q28729764-2E410CFF-3A53-471B-B023-5C2C80F4AB8D Q28729915-7A8B0E7A-3EB8-43BD-8BEF-05A2065E2903 Q28804076-DF967C7C-B458-4970-9EB2-6885F2C72483 Q28804225-5E39598D-2165-4E77-A483-DF9EBF8D0FAE Q28950443-1CCB96B7-2671-4545-B53C-694108FF6B1C Q29994510-0FED6075-8D9C-4C0B-86D6-DE5DEF880375 Q30250932-B6C40616-32D7-450A-89FA-5F1491978C7F Q33681310-F94F57F4-1C5C-4FA5-B4ED-49539E834017 Q33867337-8D7DE3B5-57F8-49D8-9A68-5054622DDABB Q33924674-B180EADA-8A00-4B50-82B2-4747E17F6D33 Q36205859-2F42D202-CF41-4BE3-9A28-57B23FAE02E2 Q36597801-F83541A6-36A5-48C6-8175-D174B10DD923 Q37642687-123622D6-0CAC-4C67-83B7-A5CC5B4609CE Q37661008-0C9F3A65-AD6D-4E7F-B8A9-203988BF478B Q38636217-A6B16804-FD7F-4E5B-89CC-5F6E1ECB832C Q38652971-7A0596F5-5787-4B6E-871F-82E39E48D945 Q38769771-13E807EE-E5B4-4F62-B353-9F9BD93232A7 Q38816571-5F89EBF9-C542-49D7-AEFE-CC99B1EF307B Q38948606-BB1A1A07-70C1-4AED-9B3F-73A66C6899FB Q38994574-C553E412-FCE0-4879-936A-97F7303AA525 Q39017347-AE548DF4-A3D2-4FD3-91BC-B8810132A39B Q39172722-C205CF3F-425B-4F2E-96BC-B4E95644F2C2 Q39375868-3C6AD6F7-E3E4-4C87-85B5-C963DD6AD438 Q39535403-7119AA2E-F898-4EA6-925D-D37AED91D240 Q40043685-6A380B3E-8E80-43CB-B3EB-5256714902F1 Q40047887-A9557D3D-1B15-41FE-B28F-DF31794444BC Q40142572-D8A6A7EA-FCF2-4DD1-9866-B65312B0D582 Q40143286-9CCB1CB8-7B72-48C8-9DAD-2A0E7B8895A2

P2860

DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers

http://www.wikidata.org/entity/Q36352752

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

DENGUE VIRUS. Cryo-EM structur ...... 2 by locking E protein dimers

@ast

DENGUE VIRUS. Cryo-EM structur ...... 2 by locking E protein dimers

@en

type

label

DENGUE VIRUS. Cryo-EM structur ...... 2 by locking E protein dimers

@ast

DENGUE VIRUS. Cryo-EM structur ...... 2 by locking E protein dimers

@en

prefLabel

DENGUE VIRUS. Cryo-EM structur ...... 2 by locking E protein dimers

@ast

DENGUE VIRUS. Cryo-EM structur ...... 2 by locking E protein dimers

@en

P1433

Q36352752-09FDF8B4-0007-4545-BE1A-FEBC6A0DAE00

P1476

Q36352752-70336969-9CE4-4222-9581-D7CFB7C723E0

P2093

Q36352752-6049BA3F-426A-4FA9-B0DF-DAF29993C79C

Q36352752-94FD447E-93E0-4857-A4ED-1E9CF3215A90

Q36352752-A79D9C09-94A4-4B68-9B52-94A7A96A17A2

Q36352752-B45C1E54-4029-4395-9D53-EE3017C6B105

Q36352752-D7D58698-AB60-444E-B34F-6E7061814100

Q36352752-D81A9C83-420E-4079-ABEB-5D3C1A857712

Q36352752-E5171404-29B3-4BAA-9992-5C8A79E50DB4

P2860

Q36352752-06FE52EC-8954-47DA-93D8-31C0AE9C53FF

Q36352752-1B0B574F-B95C-4457-98DD-FB5C28078488

Q36352752-209CBC46-BE83-4D1E-B114-731A0F24F467

Q36352752-25356294-F8DA-42E2-B1E8-FE88B92E4952

Q36352752-44876C8A-450F-488E-A414-1756F390076D

Q36352752-4743BADD-C7B8-4E16-81C6-11D875AD9E06

Q36352752-58543980-5009-4F6A-ACF6-D516DD958CD9

Q36352752-6FC3A88C-373D-4EEE-BB31-D158F02CE9D0

Q36352752-7BBB9214-CA02-4007-B8B1-80333A20090A

Q36352752-7DEA501E-5BFC-4244-973F-8ADEA1F52D38

P304

Q36352752-26A233B2-FA83-48CA-8DDF-A5B0A307EC96

P31

Q36352752-87601A18-FFBC-43C3-B309-BF04042FA650

P356

Q36352752-041EC958-8470-48B0-B8C1-E00DF6527FD8

P407

Q36352752-980E9D70-CD39-4328-9AF7-392A794153CE

P433

Q36352752-DE74D9BF-9744-40F7-B1BB-7AAE35116C0D

P478

Q36352752-4B00A7A1-B943-43FA-9D8B-D33729CA44A4

P50

Q36352752-21655987-F936-4F37-A241-6E77B1EA86D9

Q36352752-71A23D25-BBAE-46DA-99C7-B677733673F5

Q36352752-B1CBE36C-7844-481A-B520-8662E6FBBB00

Q36352752-CC15267C-B91F-4E15-ABF9-B01E009514A0

Q36352752-D2C2BF31-02D2-4C9E-965E-4932E941BD49

Q36352752-FB74148D-8163-4DF8-BEAB-EC4E19C1503B

P577

Q36352752-B951D8B2-B35E-4B3B-BD09-1E6CEF7BCE88

P698

Q36352752-FCA8AD07-9637-4980-B4C2-312041B7FEB5

P921

Q36352752-34AC971B-2681-4776-ADF8-B15B769BE8BA

Q36352752-499C9297-8D36-4D9E-AFD2-9AFDB5CF9F8E

Q36352752-667554EC-14A4-499C-BC51-7BA82FCA787F

Q36352752-6F9AAF65-DBB1-401D-8D6D-AF4C970C5AA3

P932

Q36352752-DB388FEE-B084-44E7-AB93-8108BDE7AB99

P356

SCIENCE.AAA8651

P1433

P1476

DENGUE VIRUS. Cryo-EM structur ...... 2 by locking E protein dimers

@en

P2093

Jiaqi Wang

http://www.w3.org/2001/XMLSchema#string

Joanne L Tan

http://www.w3.org/2001/XMLSchema#string

Justin S G Ooi

http://www.w3.org/2001/XMLSchema#string

Kristie D Ibarra

http://www.w3.org/2001/XMLSchema#string

Scott A Smith

http://www.w3.org/2001/XMLSchema#string

Shee-Mei Lok

http://www.w3.org/2001/XMLSchema#string

Thiam-Seng Ng

http://www.w3.org/2001/XMLSchema#string

P2860

The global distribution and burden of dengue

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Improved methods for building protein models in electron density maps and the location of errors in these models

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

Infection of human cells by dengue virus is modulated by different cell types and viral strains

Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability

Cryo-EM structure of the mature dengue virus at 3.5-Å resolution

Dengue structure differs at the temperatures of its human and mosquito hosts

Structural Changes in Dengue Virus When Exposed to a Temperature of 37 C

The structural basis for serotype-specific neutralization of dengue virus by a human antibody

P304

88-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.AAA8651

http://www.w3.org/2001/XMLSchema#string

P407

P433

6243

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P50

Victor A Kostyuchenko

Aravinda de Silva

James E. Crowe Jr.

Guntur Fibriansah

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26138979

http://www.w3.org/2001/XMLSchema#string

P921

cryogenic electron microscopy

protein structure

P932

4672004

http://www.w3.org/2001/XMLSchema#string